CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Reconciliation of net loss to net cash used in operating activities:
Net loss	$ (973,946)	$ (1,582,970)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	22,189	16,237
Amortization of debt discounts	48,574	27,922
Loss (gain) on conversion of interest		72,765
Warrants issued for services	30,703	61,211
Common stock issued for services		7,656
Loss on extension of warrants		206,620
Employee stock option compensation expense	64,208	157,464
Changes in assets and liabilities:
Accounts receivable	(100,276)	118,407
Inventories	(99,863)	47,993
Prepaid expenses and other current assets	13,237	33,721
Accounts payable	48,622	(114,236)
Accrued expenses	152,764	147,757
Settlement accrual	(26,789)	(80,000)
Deferred revenue	(4,000)
Net cash used in operating activities	(824,577)	(879,453)
Cash flows from Investing Activities
Purchases of equipment	(1,257)	(52,358)
Net cash used in investing activities	(1,257)	(52,358)
Cash flows from Financing Activities
Proceeds from sale of stock under stock purchase agreement	123,620	225,245
Proceeds from sale of stock and warrants	500,000
Proceeds from advances on convertible line of credit with related parties	200,000	680,000
Payments on insurance finance contract	(24,323)	(26,214)
Net cash provided by financing activities	799,297	879,031
Net (decrease) increase in cash and cash equivalents	(26,537)	(52,780)
Cash and cash equivalents - beginning	151,184	135,266
Cash and cash equivalents - ending	124,647	82,486
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	773	835
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Beneficial conversion feature of convertible notes	9,661	61,637
Loan discount from warrants	9,661	61,637
Stock issued for accrued interest		$ 149,811